Kerry Klussman

4.3k citations

37 papers · 3.4k indexed · 2 hit papers · h-index 19

Impact in

Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Immunology and Allergy top 1%
- Cell Adhesion Molecules Research

Papers in

Immunology 19
- T-cell and B-cell Immunology 13
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 6
Radiology, Nuclear Medicine and Imaging 19
- Monoclonal and Polyclonal Antibodies Research 19

Co-authors: Alejandro Aruffo Nitin K. Damle Peter S. Linsley Alan F. Wahl Che‐Leung Law Robert S. Mittler Peter D. Senter Kristine A. Gordon
Journals: Cancer Research (9 papers)The Journal of Immunology (7 papers)Blood (7 papers)Clinical Cancer Research (2 papers)The Journal of Experimental Medicine (2 papers)
Partner nations: United States Germany Sweden

In The Last Decade

Kerry Klussman

36 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity 2003 · 668 citations

Peers

Countries citing papers authored by Kerry Klussman

Since Specialization

Citations

This map shows the geographic impact of Kerry Klussman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Klussman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Klussman more than expected).

Fields of papers citing papers by Kerry Klussman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry Klussman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Klussman. The network helps show where Kerry Klussman may publish in the future.

Co-authors

The 25 scholars most cited alongside Kerry Klussman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kerry Klussman Line = papers co-authored together Kerry Klussman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 1522: SGN-B6A induces immunogenic cell death as an additional mechanism of action Cancer Research ·Vivian H. Trang, Rebecca Mazahreh, John J. Gosink, Michelle Ulrich, Devra J. Olson, Allana Ubben, Sean Allred, Liya Huang, Kelly Hensley, Piper M. Treuting, Kerry Klussman, Shaylin Higgins, Patrick Younan, Roma Yumul, Natalya Nazarenko, Robert P. Lyon	2023	2
2	SGN-B6A: A New Vedotin Antibody–Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications Molecular Cancer Therapeutics ·Robert P. Lyon, Mechthild Jonas, Christopher Frantz, Esther S. Trueblood, Roma Yumul, Lori Westendorf, Christopher Hale, Jackie L. Stilwell, Narayana Yeddula, Katie M. Snead, Vineet Kumar, Gabriela I. Patilea‐Vrana, Kerry Klussman, Maureen C. Ryan	2023	12
3	Abstract 2013: Oxidized anthracycline payloads induce anti-tumor immunogenic cell-death and show linker-dependent tolerability when delivered as ADCs Cancer Research ·Joseph Z. Hamilton, Kerry Klussman, Rebecca Mahzereh, Jessica K. Simmons, Michelle Ulrich, Shyra J. Gardai, Peter D. Senter, Patrick Burke	2023	2
4	Denintuzumab Mafodotin Stimulates Immune Responses and Synergizes with CD20 Antibodies to Heighten Anti-Tumor Activity in Preclinical Models of Non-Hodgkin Lymphoma Blood ·Heather A. Van Epps, Ryan A. Heiser, Anthony Cao, Kerry Klussman, Changpu Yu, Ivan J. Stone, Jason Neale, Shyra J. Gardai, Che‐Leung Law, Maureen C. Ryan	2016	2
5	Abstract 2541: Preclinical results of SGN-CD19A in combination with R-ICE or R-CHOP in non-Hodgkin lymphoma models Cancer Research ·Heather A. Van Epps, Kerry Klussman, Martha E. Anderson, Weiping Zeng, Devra J. Olson, Maureen C. Ryan, Tina Albertson, Che‐Leung Law	2015	3
6	Development of orally active inhibitors of protein and cellular fucosylation Proceedings of the National Academy of Sciences ·Nicole M. Okeley, Stephen C. Alley, Martha E. Anderson, Tamar E. Boursalian, Patrick Burke, Kim M. Emmerton, Scott C. Jeffrey, Kerry Klussman, Che‐Leung Law, Django Sussman, Brian E. Toki, Lori Westendorf, Weiping Zeng, Xinqun Zhang, Dennis R. Benjamin, Peter D. Senter	2013	147
7	Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70 Clinical Cancer Research ·Julie A. McEarchern, Leia M. Smith, Charlotte F. McDonagh, Kerry Klussman, Kristine A. Gordon, Carol A. Morris-Tilden, Steven Duniho, Maureen C. Ryan, Tamar E. Boursalian, Paul J. Carter, Iqbal S. Grewal, Che‐Leung Law	2008	70
8	Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities Blood ·Julie A. McEarchern, Ezogelin Oflazoglu, Leigh Francisco, Charlotte F. McDonagh, Kristine A. Gordon, Ivan J. Stone, Kerry Klussman, Eileen Turcott, Nico van Rooijen, Paul Carter, Iqbal S. Grewal, Alan F. Wahl, Che‐Leung Law	2006	87
9	A Humanized Anti-CD70 Monoclonal Antibody Targets CD70-Expressing Multiple Myeloma. Blood ·Julie A. McEarchern, Charlotte F. McDonagh, Allen W. Ho, Yu‐Tzu Tai, Leigh Francisco, Kerry Klussman, Carol A. Morris-Tilden, Kristine A. Gordon, Ezogelin Oflazoglu, Kim M. Kissler, Nikhil C. Munshi, Kenneth C. Anderson, Steven P. Treon, Paul Carter, Alan F. Wahl, Iqbal S. Grewal, Che‐Leung Law	2005	4
10	Efficient Elimination of B-Lineage Lymphomas by Anti-CD20–Auristatin Conjugates Clinical Cancer Research ·Che‐Leung Law, Charles G. Cerveny, Kristine A. Gordon, Kerry Klussman, Bruce Mixan, Dana F. Chace, Damon L. Meyer, Svetlana O. Doronina, Clay B. Siegall, Joseph A. Francisco, Peter D. Senter, Alan F. Wahl	2004	84
11	cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity Blood ·Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer, Bruce Mixan, Kerry Klussman, Dana F. Chace, Starr X. Rejniak, Kristine A. Gordon, Ron L DeBlanc, Brian E. Toki, Che‐Leung Law, Svetlana O. Doronina, Clay B. Siegall, Peter D. Senter, Alan F. Wahl Hit paper breakdown →	2003	668
12	Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell Anergy The Journal of Experimental Medicine ·Robert S. Mittler, Tina S. Bailey, Kerry Klussman, Mark D. TrailSmith, Michael K. Hoffmann	1999	152
13	Surface Expression of CD28 Single Chain Fv for Costimulation by Tumor Cells Immunological Reviews ·Gösta Winberg, Laura S. Grosmaire, Kerry Klussman, Martha S. Hayden, H. Perry Fell, Jeffrey A. Ledbetter, Robert S. Mittler	1996	18
14	Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. The Journal of Immunology ·Nitin K. Damle, Kerry Klussman, Gina Leytze, Sigrid E. Myrdal, Alejandro Aruffo, J A Ledbetter, P S Linsley	1994	82
15	Activation with superantigens induces programmed death in antigen‐primed CD4⁺ class II⁺ major histocompatibility complex T lymphocytes via a CD11a/CD18‐dependent mechanism European Journal of Immunology ·Nitin K. Damle, Gina Leytze, Kerry Klussman, Jeffrey A. Ledbetter	1993	44
16	Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7 The Journal of Immunology ·Nitin K. Damle, Kerry Klussman, Gina Leytze, Peter S. Linsley	1993	54
17	Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes. The Journal of Immunology ·Nitin K. Damle, Kerry Klussman, Gina Leytze, A Aruffo, P S Linsley, J A Ledbetter	1993	93
18	GMP‐140 (P‐selectin/CD62) binds to chronically stimulated but not resting CD4⁺ T lymphocytes and regulates their production of proinflammatory cytokines European Journal of Immunology ·Nitin K. Damle, Kerry Klussman, Mary T. Dietsch, Alejandro Aruffo, Nahid Mohagheghpour	1992	84
19	Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes The Journal of Immunology ·Nitin K. Damle, Kerry Klussman, Peter S. Linsley, Alejandro Aruffo	1992	362
20	Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7 The Journal of Immunology ·Nitin K. Damle, Kerry Klussman, P S Linsley, Alejandro Aruffo, J A Ledbetter	1992	72

About Kerry Klussman

Kerry Klussman is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Oncology, Immunology and Allergy and Hematology, having authored 37 papers that have together received 3.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), T-cell and B-cell Immunology (13 papers), Glycosylation and Glycoproteins Research (9 papers), Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Immunology (1.8k citations), Immunology and Allergy (461 citations), Oncology (1.4k citations), Radiology, Nuclear Medicine and Imaging (938 citations) and Pathology and Forensic Medicine (431 citations). Kerry Klussman has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Alejandro Aruffo, Nitin K. Damle, Peter S. Linsley, Alan F. Wahl, Che‐Leung Law, Robert S. Mittler, Peter D. Senter, Kristine A. Gordon, Joseph A. Francisco and Clay B. Siegall. Their work appears in journals such as Cancer Research, The Journal of Immunology, Blood, Clinical Cancer Research and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact